Stock Market Cafe
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Stock Market Cafe
No Result
View All Result
Home Trading News

FDA expands eligibility for Pfizer Covid booster shots to 16- and 17-year-olds amid omicron fears

by
December 9, 2021
in Trading News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Inflation Adjusted House Prices 3.4% Below Peak; Price-to-rent index is 7.4% below recent peak

Forget About ‘Timing the Market’: Schwab Research Reveals the Optimal Way to Invest

A 16-year-old teenager, receives a dose of the Pfizer-BioNtech COVID-19 coronavirus vaccine.

Jack Guez | AFP | Getty Images

The Food and Drug Administration on Thursday expanded eligibility for Pfizer and BioNTech’s booster shot to people who are 16 and 17 years old at least six months after their primary vaccination.

The FDA’s emergency authorization comes a day after Pfizer and BioNTech released initial lab data indicating that booster shots provide high levels of protection against the highly mutated omicron variant of the virus that causes Covid-19.

The preliminary data found that omicron significantly reduces the protection provided by the initial two-dose series. Boosters, on the other hand, fight the variant at levels comparable to the 95% protection provided by the two-dose series against the original strain of the virus, the lab results showed.

“As people gather indoors with family and friends for the holidays, we can’t let up on all the preventive public health measures that we have been taking during the pandemic,” acting FDA Commissioner Janet Woodcock said in a press release. “With both the delta and omicron variants continuing to spread, vaccination remains the best protection against COVID-19.”

The Centers for Disease Control and Prevention still needs to authorize boosters for 16- and 17-year-olds before the shots are administered. The CDC cleared booster shots for all adults 18 and over last month.

Public health authorities in the U.S. are calling for everyone who is eligible to get a booster shot, amid fears of a winter Covid surge driven by the delta variant and uncertainty about the future course of the pandemic due to omicron.

The efficacy of the initial two-dose vaccination series was declining before the arrival of omicron.

This is breaking news. Please check back for updates.

ShareTweetPin

Related Posts

Inflation Adjusted House Prices 3.4% Below Peak; Price-to-rent index is 7.4% below recent peak

by
September 27, 2023
0

Forget About ‘Timing the Market’: Schwab Research Reveals the Optimal Way to Invest

by
September 27, 2023
0

MBA: Mortgage Applications Decreased in Weekly Survey

by
September 27, 2023
0

Daily Spotlight: Fed’s Favorite Inflation Indicator Out Friday

by
September 27, 2023
0

Warren Buffett Says Apple Is Better Than Any Businesses Berkshire Owns — Unmatched Brand Loyalty Proven As Consumers Would Give Up A Second Car For An iPhone

by
September 27, 2023
0

Next Post

Fed's Flow of Funds: Household Net Worth Increased $2.4 Trillion in Q3

I’ve processed more than 1,000 mortgages. Here are 3 things buyers in today’s market should do before they get a mortgage

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Crocs sees fourth-quarter sales up 42%, CEO Andrew Rees says 2021 was ‘exceptional year’

    0 shares
    Share 0 Tweet 0
  • Biden didn’t accept Putin’s ‘red lines’ on Ukraine – here’s what that means

    0 shares
    Share 0 Tweet 0
  • Ford partners with GlobalFoundries to increase chip supplies

    0 shares
    Share 0 Tweet 0
  • CEOs across the market, economy agree on one big 2022 prediction: More volatility

    0 shares
    Share 0 Tweet 0
  • Inflation is sticking around – and Biden will likely have to wait it out like the rest of us

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.stockmarket-cafe.com
No Result
View All Result
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.stockmarket-cafe.com